We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Clinical Trial Investigator Faces SEC Charges of Insider Trading
Clinical Trial Investigator Faces SEC Charges of Insider Trading
November 10, 2010
A clinical researcher who could be facing up to 25 years in prison for allegedly tipping off a hedge fund manager about negative trial results is listed as an investigator for ongoing clinical trials by Novo Nordisk and Bristol Myers-Squib (BMS) and has consulted for many drug companies.